Company attributes
Location
Country
No article content yet.
Timeline
No Timeline data yet.
Funding Rounds
Products
Acquisitions
SBIR/STTR Awards
Patents
Further Resources
No Further Resources data yet.
BioIntervene is a first-in-class, selective A3 adenosine receptor agonists.
